Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases
Identifieur interne : 000013 ( Istex/Curation ); précédent : 000012; suivant : 000014Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases
Auteurs : Gil Klinger [Canada] ; Yair Morad [Canada] ; Carol A. Westall [Canada] ; Carl Laskin [Canada] ; Karen A. Spitzer [Canada] ; Gideon Koren [Canada] ; Shinya Ito [Canada] ; Raymond J. Buncic [Canada]Source :
- The Lancet [ 0140-6736 ] ; 2001.
English descriptors
- Teeft :
- Abnormality, Acuity, Canadian institute, Chloroquine, Colour, Cystic, Cystic fibrosis, First trimester exposure, Frcs, Health research, Heart lung transplant, Hydrochloroquine, Hydroxychloroquine, Koren, Lancet, Lancet publishing group, Liver disease, Liver transplantation, Motherisk programme, Ocular toxicity, Ophthalmological, Ophthalmological abnormalities, Ophthalmological examination, Pigmentary retinopathy, Pregnancy outcome, Programme, Rheumatoid arthritis, Risk factors, Sick children, Systemic lupus erythematosus, Toxicity, Transplant, Transplantation, Visual abnormalities, Visual acuity, Visual fields.
Abstract
Summary: Chronic use of chloroquine and hydroxychloroquine in the treatment of rheumatic disease carries a small risk of sight-threatening pigmentary retinopathy. To obtain safety data for its use in pregnancy, we did ophthalmic examinations in 21 children born to women who took these drugs during pregnancy. Average daily maternal doses of the two drugs were 317 mg hydroxychloroquine and 332 mg chloroquine. The mean duration of gestational exposure was 72 months. No ophthalmic abnormality was detected in these children. Therapeutic use of these drugs during pregnancy may not pose a significant risk of ocular toxicity to offspring.
Url:
DOI: 10.1016/S0140-6736(01)06004-4
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000013
Links to Exploration step
ISTEX:0D6C97353512CBEBA76BBDB8FF1E76D6C8D5A824Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases</title><author><name sortKey="Klinger, Gil" sort="Klinger, Gil" uniqKey="Klinger G" first="Gil" last="Klinger">Gil Klinger</name><affiliation wicri:level="1"><mods:affiliation>The Motherisk Programme, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics University of Toronto, Toronto, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>The Motherisk Programme, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics University of Toronto, Toronto</wicri:regionArea></affiliation></author><author><name sortKey="Morad, Yair" sort="Morad, Yair" uniqKey="Morad Y" first="Yair" last="Morad">Yair Morad</name><affiliation wicri:level="1"><mods:affiliation>Department of Ophthalmology, Hospital for Sick Children, University of Toronto, Toronto, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Ophthalmology, Hospital for Sick Children, University of Toronto, Toronto</wicri:regionArea></affiliation></author><author><name sortKey="Westall, Carol A" sort="Westall, Carol A" uniqKey="Westall C" first="Carol A" last="Westall">Carol A. Westall</name><affiliation wicri:level="1"><mods:affiliation>Department of Ophthalmology, Hospital for Sick Children, University of Toronto, Toronto, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Ophthalmology, Hospital for Sick Children, University of Toronto, Toronto</wicri:regionArea></affiliation></author><author><name sortKey="Laskin, Carl" sort="Laskin, Carl" uniqKey="Laskin C" first="Carl" last="Laskin">Carl Laskin</name><affiliation wicri:level="4"><mods:affiliation>Departments of Medicine and Obstetrics and Gynecology, epartments of Medicine and Obstetrics and Gynecology University of Toronto, Toronto University of Toronto, Toronto</mods:affiliation><orgName type="university">Université de Toronto</orgName><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Spitzer, Karen A" sort="Spitzer, Karen A" uniqKey="Spitzer K" first="Karen A" last="Spitzer">Karen A. Spitzer</name><affiliation wicri:level="4"><mods:affiliation>Departments of Medicine and Obstetrics and Gynecology, epartments of Medicine and Obstetrics and Gynecology University of Toronto, Toronto University of Toronto, Toronto</mods:affiliation><orgName type="university">Université de Toronto</orgName><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Koren, Gideon" sort="Koren, Gideon" uniqKey="Koren G" first="Gideon" last="Koren">Gideon Koren</name><affiliation wicri:level="1"><mods:affiliation>The Motherisk Programme, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics University of Toronto, Toronto, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>The Motherisk Programme, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics University of Toronto, Toronto</wicri:regionArea></affiliation></author><author><name sortKey="Ito, Shinya" sort="Ito, Shinya" uniqKey="Ito S" first="Shinya" last="Ito">Shinya Ito</name><affiliation wicri:level="1"><mods:affiliation>E-mail: shinya.ito@sickkids.ca</mods:affiliation><country wicri:rule="url">Canada</country></affiliation><affiliation wicri:level="1"><mods:affiliation>The Motherisk Programme, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics University of Toronto, Toronto, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>The Motherisk Programme, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics University of Toronto, Toronto</wicri:regionArea></affiliation></author><author><name sortKey="Buncic, Raymond J" sort="Buncic, Raymond J" uniqKey="Buncic R" first="Raymond J" last="Buncic">Raymond J. Buncic</name><affiliation wicri:level="1"><mods:affiliation>Department of Ophthalmology, Hospital for Sick Children, University of Toronto, Toronto, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Ophthalmology, Hospital for Sick Children, University of Toronto, Toronto</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:0D6C97353512CBEBA76BBDB8FF1E76D6C8D5A824</idno><date when="2001" year="2001">2001</date><idno type="doi">10.1016/S0140-6736(01)06004-4</idno><idno type="url">https://api.istex.fr/ark:/67375/6H6-L364SQJS-P/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000013</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000013</idno><idno type="wicri:Area/Istex/Curation">000013</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases</title><author><name sortKey="Klinger, Gil" sort="Klinger, Gil" uniqKey="Klinger G" first="Gil" last="Klinger">Gil Klinger</name><affiliation wicri:level="1"><mods:affiliation>The Motherisk Programme, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics University of Toronto, Toronto, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>The Motherisk Programme, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics University of Toronto, Toronto</wicri:regionArea></affiliation></author><author><name sortKey="Morad, Yair" sort="Morad, Yair" uniqKey="Morad Y" first="Yair" last="Morad">Yair Morad</name><affiliation wicri:level="1"><mods:affiliation>Department of Ophthalmology, Hospital for Sick Children, University of Toronto, Toronto, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Ophthalmology, Hospital for Sick Children, University of Toronto, Toronto</wicri:regionArea></affiliation></author><author><name sortKey="Westall, Carol A" sort="Westall, Carol A" uniqKey="Westall C" first="Carol A" last="Westall">Carol A. Westall</name><affiliation wicri:level="1"><mods:affiliation>Department of Ophthalmology, Hospital for Sick Children, University of Toronto, Toronto, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Ophthalmology, Hospital for Sick Children, University of Toronto, Toronto</wicri:regionArea></affiliation></author><author><name sortKey="Laskin, Carl" sort="Laskin, Carl" uniqKey="Laskin C" first="Carl" last="Laskin">Carl Laskin</name><affiliation wicri:level="4"><mods:affiliation>Departments of Medicine and Obstetrics and Gynecology, epartments of Medicine and Obstetrics and Gynecology University of Toronto, Toronto University of Toronto, Toronto</mods:affiliation><orgName type="university">Université de Toronto</orgName><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Spitzer, Karen A" sort="Spitzer, Karen A" uniqKey="Spitzer K" first="Karen A" last="Spitzer">Karen A. Spitzer</name><affiliation wicri:level="4"><mods:affiliation>Departments of Medicine and Obstetrics and Gynecology, epartments of Medicine and Obstetrics and Gynecology University of Toronto, Toronto University of Toronto, Toronto</mods:affiliation><orgName type="university">Université de Toronto</orgName><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Koren, Gideon" sort="Koren, Gideon" uniqKey="Koren G" first="Gideon" last="Koren">Gideon Koren</name><affiliation wicri:level="1"><mods:affiliation>The Motherisk Programme, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics University of Toronto, Toronto, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>The Motherisk Programme, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics University of Toronto, Toronto</wicri:regionArea></affiliation></author><author><name sortKey="Ito, Shinya" sort="Ito, Shinya" uniqKey="Ito S" first="Shinya" last="Ito">Shinya Ito</name><affiliation wicri:level="1"><mods:affiliation>E-mail: shinya.ito@sickkids.ca</mods:affiliation><country wicri:rule="url">Canada</country></affiliation><affiliation wicri:level="1"><mods:affiliation>The Motherisk Programme, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics University of Toronto, Toronto, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>The Motherisk Programme, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics University of Toronto, Toronto</wicri:regionArea></affiliation></author><author><name sortKey="Buncic, Raymond J" sort="Buncic, Raymond J" uniqKey="Buncic R" first="Raymond J" last="Buncic">Raymond J. Buncic</name><affiliation wicri:level="1"><mods:affiliation>Department of Ophthalmology, Hospital for Sick Children, University of Toronto, Toronto, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Ophthalmology, Hospital for Sick Children, University of Toronto, Toronto</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">The Lancet</title><title level="j" type="abbrev">LANCET</title><idno type="ISSN">0140-6736</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="2001">2001</date><biblScope unit="volume">358</biblScope><biblScope unit="issue">9284</biblScope><biblScope unit="page" from="813">813</biblScope><biblScope unit="page" to="814">814</biblScope></imprint><idno type="ISSN">0140-6736</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0140-6736</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Abnormality</term><term>Acuity</term><term>Canadian institute</term><term>Chloroquine</term><term>Colour</term><term>Cystic</term><term>Cystic fibrosis</term><term>First trimester exposure</term><term>Frcs</term><term>Health research</term><term>Heart lung transplant</term><term>Hydrochloroquine</term><term>Hydroxychloroquine</term><term>Koren</term><term>Lancet</term><term>Lancet publishing group</term><term>Liver disease</term><term>Liver transplantation</term><term>Motherisk programme</term><term>Ocular toxicity</term><term>Ophthalmological</term><term>Ophthalmological abnormalities</term><term>Ophthalmological examination</term><term>Pigmentary retinopathy</term><term>Pregnancy outcome</term><term>Programme</term><term>Rheumatoid arthritis</term><term>Risk factors</term><term>Sick children</term><term>Systemic lupus erythematosus</term><term>Toxicity</term><term>Transplant</term><term>Transplantation</term><term>Visual abnormalities</term><term>Visual acuity</term><term>Visual fields</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Summary: Chronic use of chloroquine and hydroxychloroquine in the treatment of rheumatic disease carries a small risk of sight-threatening pigmentary retinopathy. To obtain safety data for its use in pregnancy, we did ophthalmic examinations in 21 children born to women who took these drugs during pregnancy. Average daily maternal doses of the two drugs were 317 mg hydroxychloroquine and 332 mg chloroquine. The mean duration of gestational exposure was 72 months. No ophthalmic abnormality was detected in these children. Therapeutic use of these drugs during pregnancy may not pose a significant risk of ocular toxicity to offspring.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000013 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000013 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:0D6C97353512CBEBA76BBDB8FF1E76D6C8D5A824
|texte= Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases
}}
| This area was generated with Dilib version V0.6.33. |  |